| Group control (n = 60) | Group IoC (n = 60) | t/χ2-value | P-value | SE difference (95%Cl) |
---|---|---|---|---|---|
Cerebral complications [n (%)] | 0 | 0 | —— | —— | —— |
Cardiac complications [n (%)] | 2(3.3) | 1(1.7) | 0.000 | 1.000b | —— |
Pulmonary complications [n (%)] | 1(1.7) | 0(1.7) | —— | 1.000b | —— |
Renal complications [n (%)] | 4(6.7) | 1(1.7) | 0.835 | 0.361b | —— |
Urinary tract infection [n (%)] | 9(13.3) | 5(8.3) | 1.294 | 0.255b | —— |
Total complications [n (%)] | 16(26.7) | 7(11.7) | 4.357 | 0.037b | —— |
Hospital stays(days) | 15.02 ± 7.42 | 13.10 ± 5.13 | 1.649 | 0.102a | 4.42(-5.42, 9.36) |